retatrutide mechanism triple agonist gip glp-1 glucagon Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research Demonstrated metabolic effects of GIP,
Description
Broad therapeutic benefits: Beyond type 2 diabetes and obesity, it provides benefits in cardiovascular and neurodegenerative diseases, as well as MASH/NASH and related metabolic disorders
10.1186/s12933-017-0643-2 72 RasmussenI
Your muscles respond better to evenly distributed protein than getting all your protein in one huge meal
Lingvay, I
doi: 10.3390/biom13121695 29
95% CI, 0.83-0.95) (88)
